[1]Siegel R L, Miller K D, Jemal A. Cancer statistics, 2015[J].CA Cancer J Clin,2015,65(1):5
[2]韩苏军,张思维,陈万青,等.中国前列腺癌发病现状和流行趋势分析[J].临床肿瘤学杂志,2013,18(4):330
[3]Siegel R, Ma J M, Zou Z H, et al. Cancer statistics, 2014[J].CA Cancer J Clin,2014,64(1):9
[4]Gleason D.Histologic grading of prostate cancer: a perspective[J].Hum Pathol,1992,23(3):273
[5]Rubin M, Girelli G, Demichelis F. Genomic correlates to the newly proposed grading prognostic groups for prostate cancer[J].Eur Urol,2016,69(4):557
[6]Vira M, Guzzo T, Heitjan D, et al. Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known[J].BJU Int,2008,101(10):1232
[7]Lau W, Blute M, Bostwick D, et al. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4[J].J Urol,2001, 166(5):1692
[8]Gleason D F. Classification of prostatic carcinomas[J].Cancer Chemother Rep,1966,50(3):125
[9]Wright J, Salinas C, Lin D, et al. Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort[J].J Urol,2009,182(6):2702
[10]彭鹏,龚杨明,鲍萍萍,等.中国2008年前列腺癌发病、死亡和患病情况的估计及预测[J].中华流行病学杂志,2012,33(10):1056
[11]Kelly T, Yang W, Chen C S, et al. Global burden of obesity in 2005 and projections to 2030[J].Int J Obes (Lond),2008,32(9):1431
[12]Calle E E, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults[J].N Engl J Med,2003,348(17):1625
[13] Bassett J K, Severi G, Baglietto L, et al. Weight change and prostate cancer incidence and mortality[J]. Int J Cancer,2012,131(7):1711
[14]Bai P, Hu M, Xu H, et al. Body mass index is associated with higher Gleason score and biochemical recurrence risk following radical prostatectomy in Chinese men: a retrospective cohort study and meta-analysis[J].World J Surg Oncol,2015,13(1):311
[15]Rietbergen J, Hoedemaeker R, Kruger A, et al. The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study[J].J Urol,1999,161(4):1192
[16]Kim E, Andriole G. Prostate-specific antigen-based screening: controversy and guidelines[J].BMC Med,2015,13:61
[17]Kim S, Jeong T, Yoo D, et al. Can Prostate-Specific antigen kinetics before prostate biopsy predict the malignant potential of prostate cancer[J].Yonsei Med J,2015,56(6):1492
[18]Ren S, Wang F, Shen J, et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer[J].Eur J Cancer,2013,49(13):2949
[19]Tosoian J, Reyes D, Gorin M, et al. A novel approach for performing bone marrow aspiration at the time of radical prostatectomy[J]. Urol Case Rep.2016,6(6):45
[20]Scosyrev E, Messing E, Mohile S, et al. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality[J].Cancer,2012,118(12):3062
[21]Hess K R, Varadhachary G R, Taylor S H, et al. Metastatic patterns in adenocarcinoma[J].Cancer,2006,106(7):1624
[22]Gandaglia G, Abdollah F, Schiffmann J, et al. Distribution of metastatic sites in patients with prostate cancer: A population-based analysis[J].Prostate,2014,74(2):210
[23]Sauter G, Steurer S, Clauditz T, et al. Clinical utility of quantitative gleason grading in prostate biopsies and prostatectomy specimens[J].Eur Urol,2016,69(4):592
[1]魏强,齐灿,罗飞,等.转移性去势抵抗性前列腺癌患者多西他赛化疗的预后分析[J].天津医科大学学报,2013,19(05):390.
[2]杨帮东,姜行康,齐 灿,等.尿液中PCA3评分对前列腺癌早期诊断的临床意义[J].天津医科大学学报,2013,19(06):487.
YANG Bang-dong,JIANG Xing-kang,QI Can,et al.Clinical significance of urinary PCA3 score to diagnose prostate cancer[J].Journal of Tianjin Medical University,2013,19(04):487.
[3]刘利维,刘春雨. MicroRNAs 与前列腺癌的表观遗传学研究进展[J].天津医科大学学报,2014,20(01):74.
[4]王 超,余泉峰,徐 勇,等.经直肠超声造影诊断前列腺癌的临床分析[J].天津医科大学学报,2014,20(05):375.
WANG Chao,YU Quan-feng,XU Yong,et al.Clinical analysis of contrast-enhanced transrectal ultrasonography for the diagnosis of prostate cancer[J].Journal of Tianjin Medical University,2014,20(04):375.
[5]张晓会,张志宏,徐 勇,等.合并症对局限性或局部晚期前列腺癌患者早期生存的影响[J].天津医科大学学报,2014,20(05):379.
ZHANG Xiao-hui,ZHANG Zhi-hong,XU Yong,et al. Influence of complications on early survival of patients with localized or locally advanced prostate cancer[J].Journal of Tianjin Medical University,2014,20(04):379.
[6]盛 镔,张 蒙,马鹏德,等.核糖体蛋白L37在前列腺癌中的表达及临床意义[J].天津医科大学学报,2015,21(05):401.
SHENG Bin,ZHANG Meng,MA Peng-de,et al.Expression of ribosomal protein L37 in prostate cancer and its clinical significance[J].Journal of Tianjin Medical University,2015,21(04):401.
[7]管明秀,周云丽,王 萌,等.TuM2-PK,tPSA,fPSA/tPSA和PSAD对PSA灰区前列腺癌诊断价值的比较[J].天津医科大学学报,2016,22(02):140.
GUAN Ming-xiu,ZHOU Yun-li,WANG-Meng,et al.Diagnostic implication of TuM2-PK, tPSA, fPSA/tPSA ratio and PSAD for prostate cancer in PSA gray area[J].Journal of Tianjin Medical University,2016,22(04):140.
[8]李 江,张恩龙,赵 阳,等.前列腺癌靶向磁共振成像和光热治疗的实验研究[J].天津医科大学学报,2017,23(02):93.
LI Jiang,ZHANG En-long,ZHAO Yang,et al.?Experimental research of targeted magnetic resonance imaging and photo thermal therapy for prostate cancer [J].Journal of Tianjin Medical University,2017,23(04):93.
[9]张一然,潘盼,连振鹏,等.磁共振扫描对经直肠超声引导前列腺穿刺活检的影响[J].天津医科大学学报,2017,23(02):99.
ZHANG Yi-ran,PAN Pan,LIAN Zhen-peng,et al.Effect of magnetic resonance imaging scan on the?transrectal ultrasound?prostate biopsy[J].Journal of Tianjin Medical University,2017,23(04):99.
[10]薄志强,孙桂江,王 丽,等.CtBP2异常表达对前列腺癌PC3细胞增殖效应影响的研究[J].天津医科大学学报,2017,23(02):103.
BO Zhi-qiang,SUNGui-jiang,WANG Li,et al.Effect of abnormal expression of CtBP2 on the proliferation of prostate cancer cell line PC3[J].Journal of Tianjin Medical University,2017,23(04):103.